Hodgkin Lymphoma News

• EHA 2022 A New First-line Regimen for Advanced Hodgkin Lymphoma? Patients receiving brentuximab vedotin plus chemotherapy demonstrated a significant improvement in overall survival at 6 years compared with those on standard chemotherapy.
  Medscape Medical News, June 10, 2022
• ASCO 2022 Enhertu Benefit in HER2-Low Breast Cancer: 'Practice Changing' Breast cancer patients with low levels of HER2 expression, previously considered untreatable with HER2-targeted therapies, had improved progression-free survival with trastuzumab deruxtecan (Enhertu).
  Medscape Medical News, June 06, 2022
• Woman Who Faked Cancer Gets 5 Years in Prison Amanda Christine Riley falsely claimed that she had Hodgkin's lymphoma and made more than $100,000 in donations through social media.
  Medscape Medical News, June 02, 2022
• Overlooked: Black Woman Doctor's Key Role in Oncology History Jane Cooke Wright, one of the first Black women doctors upon earning her MD in 1945, played a key role in the development of oncology as a medical specialty, and was one of the founding members of ASCO.
  Medscape Medical News, May 27, 2022
• Risk of Dying From New Cancer Higher in Young Cancer Survivors Adolescent and young adult cancer survivors are at an increased risk of developing and dying from a second primary cancer, highlighting the critical role of surveillance and survivorship care.
  Medscape Medical News, May 12, 2022
• Alert FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer With a standard approval from the FDA, the HER2-directed antibody drug conjugate can now be used earlier in treatment to delay disease progression.
  FDA Approvals, May 05, 2022
• ESMO BCC 2022 'No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer However, combining nivolumab with trastuzumab deruxtecan in advanced, pretreated breast cancer did demonstrate antitumor activity, new data show.
  Medscape Medical News, May 05, 2022
• 'Unprecedented Crisis': Hodgkin Drug Shortage Persists In a recent review, researchers went back decades to find the best alternative treatment for patients with advanced classical Hodgkin lymphoma.
  Medscape Medical News, May 04, 2022
• High Suicide, Depression Risks for Patients With Cancer Two comprehensive studies provide strong evidence of the psychological impact cancer diagnoses and treatment can have on patients and reveal the need to ramp up mental health services.
  Medscape Medical News, April 25, 2022
• Mother and Baby Fine After First Reported Use of Immune-checkpoint Inhibitor During Pregnancy A woman who suffered a relapse of classic Hodgkin lymphoma while pregnant was successfully treated with the immune-checkpoint inhibitor nivolumab, in what is believed to be the first reported case in the literature.
  Reuters Health Information, April 18, 2022
• When ImmunoTx Fails, HL Patients Should Get Timely Allo-HCT Physicians treating Hodgkin lymphoma should not delay allo-HCT over fears of checkpoint inhibitor-related graft-versus-host disease.
  Medscape Medical News, April 18, 2022
• Survivor's Story Foreshadows One of Oncology's Greatest Successes A patient's story illustrates the tremendous improvement in lymphoma treatments over the last three decades.
  Medscape Medical News, April 18, 2022
• Can Cancer Blood Tests Live Up to Promise of Saving Lives? The Canby, Oregon, resident had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people.
  Associated Press, April 11, 2022
• AACR 2022 'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy Activated natural killer cells combined with a bispecific antibody showed strong activity in heavily pretreated patients with lymphoma expressing the CD30 antigen.
  Medscape Medical News, April 11, 2022
• Ethnic Disparities in Cancer Incidence: First New Data in 10 Years Most cancer cases in England occur in White individuals, broadly reflecting the ethnic makeup of the population, but with some notable exceptions in minority groups.
  Medscape Medical News, March 18, 2022
• Breast Cancer Trials Enrolling Now: Could Your Patient Benefit? Maybe one of your patients could benefit from clinical trials that are currently recruiting patients with breast cancer.
  Medscape Medical News, February 16, 2022
• Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma Vitiligo can occur in any type of cancer, according to a new study published as a preprint and that has not yet peer reviewed.
  First Look, February 15, 2022
• 'New Standard of Care' for HER2-Mutant NSCLC? Patients with non–small cell lung cancer harboring HER2 mutations experienced durable activity and promising survival outcomes with trastuzumab deruxtecan, a new study shows.
  Medscape Medical News, January 19, 2022
• New Combo Therapy for Breast Implant–Associated Lymphoma Women who develop breast implant–associated anaplastic large-cell lymphoma can achieve good outcomes with chemotherapy plus brentuximab vedotin.
  Medscape Medical News, January 18, 2022
• ASH 2021 Novel Agents for Adult ALL: Is it Curtains for Chemo? Tyrosine kinase inhibitors and novel agents like bi-specific T-cell engager and antibody drug conjugates have diminished the need for chemotherapy in adults with acute lymphoblastic leukemia (ALL).
  Medscape Medical News, December 21, 2021